Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 2/20 | 0.66 |
| ▸ | GSK3B | P49841 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | WRN | Q14191 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12749846 | 0.80 | GSK3A (0.74) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL6422039 | 0.80 | GSK3A (0.45) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL5165436 | 0.79 | KAT2B (0.49) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL3384734 | 0.79 | GSK3A (1.00) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL13323652 | 0.79 | GSK3A (0.52) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL7097517 | 0.79 | GSK3A (0.66) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL14789789 | 0.78 | GSK3A (0.59) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL14423073 | 0.77 | GSK3A (0.58) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL5165562 | 0.76 | GSK3A (0.73) | GSK3AGSK3BALDH1A1BLMCYP1A2 | |
| SCHEMBL5161619 | 0.76 | MGLL (0.54) | GSK3AGSK3BALDH1A1BLMCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795195-B2 | Antibody-drug conjugates including hemiasterlin derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11639327-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| US-11174217-B2 | Polymerizable compound and liquid crystal composition | DIC CORPORATION (JP) | 2021-11-16 | — | — | US | disclosed |
| US-20210284766-A1 | RETARDATION FILM, ELLIPTICALLY POLARIZING PLATE, AND DISPLAY DEVICE INCLUDING THE SAME | DIC CORPORATION (JP) | 2021-09-16 | — | — | US | disclosed |
| US-10947403-B2 | Dispersion and inkjet ink composition, light conversion layer, and liquid crystal display element using the dispersion | DIC CORPORATION (JP) | 2021-03-16 | — | — | US | disclosed |
| US-10914987-B2 | Complex and optical element | KYOTO UNIVERSITY (JP) | 2021-02-09 | — | — | US | disclosed |
| EP-1509555-B1 | POLYVINYL ETHERS | IMP COLLEGE INNOVATIONS LTD (GB) | 2007-10-17 | — | — | EP | disclosed |
| EP-1582548-B1 | PROCESS FOR PRODUCING POLYMERIZABLE POLYBRANCHED POLYESTER | DAINIPPON INK & CHEMICALS (JP) | 2007-03-28 | — | — | EP | disclosed |
| CN-1303130-C | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2007-03-07 | — | — | CN | disclosed |
| US-7169829-B2 | Maleimido-bearing compounds resin composition containing the same and cured articles thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-30 | — | — | US | disclosed |
| US-7141642-B2 | Process for producing polymerizable polybranched polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-03-02 | — | — | US | disclosed |
| CN-1714113-A | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2005-12-28 | — | — | CN | disclosed |
| EP-1582548-A1 | PROCESS FOR PRODUCING POLYMERIZABLE POLYBRANCHED POLYESTER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-05 | — | — | EP | disclosed |
| CN-1454400-A | Polymer solid electrolyte and battery using the same | DAINIPPON INK & CHEMICALS (JP) | 2003-11-05 | — | — | CN | disclosed |
| EP-1339127-A1 | SOLID POLYMER ELECTROLYTE AND CELL CONTAINING THE ELECTROLYTE | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | GSK3A 1255/4885GSK3B 949/4885ALDH1A1 3448/4885 |
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | SFXN1, SFXN3, SIK3 | GSK3A 2145/4885GSK3B 2101/4885ALDH1A1 3883/4885 |
| US-11174217-B2 | Polymerizable compound and liquid crystal composition | PI4KA, PKN2, KCNH3 | GSK3A 640/4885GSK3B 707/4885ALDH1A1 2918/4885 |
| US-11795195-B2 | Antibody-drug conjugates including hemiasterlin derivative | HSD3B2, HSD3B1, HSD11B2 | GSK3A 333/4885GSK3B 229/4885ALDH1A1 1287/4885 |
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | ACSL4, ACSL1, HACL2 | GSK3A 2879/4885GSK3B 3375/4885ALDH1A1 1751/4885 |
| US-11639327-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same | SKP1, PKN1, KTN1 | GSK3A 718/4885GSK3B 485/4885ALDH1A1 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.